Apogee Therapeutics Inc banner
A

Apogee Therapeutics Inc
NASDAQ:APGE

Watchlist Manager
Apogee Therapeutics Inc
NASDAQ:APGE
Watchlist
Price: 74.68 USD -0.92% Market Closed
Market Cap: $5.1B

Wall Street
Price Targets

APGE Price Targets Summary
Apogee Therapeutics Inc

Wall Street analysts forecast APGE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APGE is 106.37 USD with a low forecast of 83.83 USD and a high forecast of 143.85 USD.

Lowest
Price Target
83.83 USD
12% Upside
Average
Price Target
106.37 USD
42% Upside
Highest
Price Target
143.85 USD
93% Upside
Apogee Therapeutics Inc Competitors:
Price Targets
CDNA
CareDx Inc
43% Upside
MASI
Masimo Corp
3% Upside
SSRM
SSR Mining Inc
2% Upside
PTGX
Protagonist Therapeutics Inc
6% Upside
NNOX
Nano-X Imaging Ltd
187% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APGE's stock price target?
Price Target
106.37 USD

According to Wall Street analysts, the average 1-year price target for APGE is 106.37 USD with a low forecast of 83.83 USD and a high forecast of 143.85 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett